Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study
Sogut et al.,
Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational..,
The American Journal of Emergency Medicine, doi:10.1016/j.ajem.2020.12.014
Safety study of 152 outpatients concluding that HCQ is safe for COVID-19, was well tolerated, and was not associated with a risk of ventricular arrhythmia due to drug-induced QTc interval prolongation.
Sogut et al., 11 Dec 2020, peer-reviewed, 10 authors.
Abstract: Journal Pre-proof
Safety and efficacy of hydroxychloroquine in 152 outpatients with
confirmed COVID-19: A pilot observational study
Ozgur Sogut, Mehmet Mustafa Can, Ramazan Guven, Onur
Kaplan, Hüseyin Ergenc, Tuba Betül Ümit, Olgun Demir, Murat
Kaya, Tarık Akdemir, Sümeyye Çakmak
PII:
S0735-6757(20)31133-5
DOI:
https://doi.org/10.1016/j.ajem.2020.12.014
Reference:
YAJEM 159639
To appear in:
American Journal of Emergency Medicine
Received date:
26 September 2020
Revised date:
3 December 2020
Accepted date:
6 December 2020
Please cite this article as: O. Sogut, M.M. Can, R. Guven, et al., Safety and efficacy of
hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational
study, American Journal of Emergency Medicine (2018), https://doi.org/10.1016/
j.ajem.2020.12.014
This is a PDF file of an article that has undergone enhancements after acceptance, such
as the addition of a cover page and metadata, and formatting for readability, but it is
not yet the definitive version of record. This version will undergo additional copyediting,
typesetting and review before it is published in its final form, but we are providing this
version to give early visibility of the article. Please note that, during the production
process, errors may be discovered which could affect the content, and all legal disclaimers
that apply to the journal pertain.
© 2018 Published by Elsevier.
Journal Pre-proof
Title: Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID19: A pilot observational study
Running title: Safety and efficacy of hydroxychloroquine in outpatients with COVID-19
Order of Authors
Ozgur Sogut1, Mehmet Mustafa Can2, Ramazan Guven3, Onur Kaplan1, Hüseyin Ergenc1,
University of Health Sciences, Haseki Training and Research Hospital, Department of
ro
1
of
Tuba Betül Ümit1, Olgun Demir1, Murat Kaya1, Tarık Akdemir1, Sümeyye Çakmak4
Emergency Medicine, Istanbul, Turkey
University of Health Sciences, Haseki Training and Research Hospital, Department of
-p
2
3
re
Cardiology, Istanbul, Turkey
University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital,
University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital,
na
4
lP
Department of Emergency Medicine, Istanbul, Turkey
Department of Emergency Medicine, Istanbul, Turkey
Jo
ur
Emails of Authors
Ozgur Sogut1, Email: ozgur.sogut@sbu.edu.tr
Mehmet Mustafa Can2, mehmetmustafacan@yahoo.com
Ramazan Guven3, drramazanguven@gmail.com
Onur Kaplan1, kaplan2852@yahoo.com
Hüseyin Ergenc1, mdergenc@gmail.com
Tuba Betül Ümit1, tbumit@hotmail.com
Olgun Demir1, olgundemir512@hotmail.com
Murat Kaya1, dr.mkaya34@hotmail.com
Tarık Akdemir1, tarikakdemir52@gmail.com
1
Journal Pre-proof
Sümeyye Çakmak4, sumeyyetumturk@gmail.com
Address for correspondence and reprint requests:
Name: Ozgur Sogut
Address:
University of Health Sciences, Department of Emergency Medicine, Haseki
Research and Training Hospital, Millet Street, Zip Code: 34096, Fatih/Istanbul, Turkey.
of
Phone: +90 (212) 312 84 56/24 06
ro
E-mail: ozgur.sogut@sbu.edu.tr
Jo
ur
na
lP
re
-p
Fax: +90 (212) 313 96 15
2
Journal Pre-proof
Title: Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID19: A pilot observational study
Running title: Safety and efficacy of hydroxychloroquine in outpatients with COVID-19
ABSTRACT
Purpose: We investigated the efficacy and safety of hydroxychloroquine for..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit